ICB-PHARMA 2019 - The Third International Current Breakthrough in Pharmacy

Theme: Assembling Science and Technology for Advanced Pharmacy and Cancer Chemoprevention
16-17 November 2019
in conjunction with
The 10th Annual Conference of Indonesian Society for Cancer Chemoprevention (ISCC)
International Summit on Science Technology and Humanity (ISETH2019)

You have to login to submit ICB-Pharma 2019 papers.
For the first time user, you need to create author account.

If you forgot your password, request new password.

The 3rd ICB-Pharma invites all potential authors from universities and various organisations to submit papers in the area of pharmacy.

 

Publication:
Authors may choose SCOPUS journal, SINTA journal or ISSN Conference Proceedings.

SCOPUS Journal:
All accepted reviewed papers will be processed for second stage review prior to publication.
International Journal of Pharmaceutical Research
Journal of International Pharmaceutical Research

IJCC  Journal (Sinta 2):
All accepted reviewed papers will be processed for second stage review prior to publication.
Indonesian Journal of Cancer Chemoprevention (IJCC)

ISSN Conference Proceedings:
The accepted reviewed papers will be published in the proceedings.

Poster Presentation:
Posters must be prepared as 594 x 841 mm (width x height or A1 size) in portrait lay-out. The poster should be displayed during the conference from 8.00 – 16.00 WIB (GMT+7) and should be removed by the end of the conference.


ATTENTION (SCOPUS Publication):
  1. Use the correct template. Download HERE.
  2. Articles must be a minimum of 3,000 words to a maximum of 8,000 words. Please note that only the main text is included in the word count; the abstract, references, figure captions, and tables are not counted toward the word count.
  3. References: At least twenty (20) references.  Five (5) of the sources must be from reputable journal articles found in database such as Sciencedirect, Scopus, ProQuest, Ebsco.
  4. Authors must ensure the accuracy of citations, quotations, diagrams, tables, and maps. All in-text citations must be cited in the reference list and all sources in the reference list must be cited within the article. Sources accessed online must include a DOI or URL.
  5. References with non-English titles must include a translation. Please include translated titles in brackets following original language title.
  6. Reference and citations use APA style.

Collaborations

         


 

Publication SCOPUS Journal  
International Affiliation USD 350
Indonesian Affiliatiton IDR 4,700,000

 

Publication IJCC Journal SINTA2  
International Affiliation USD 100
Indonesian Affiliatiton IDR 1,500,000

 

Publication ISSN Proceedings  
Student IDR 750,000
Non Student IDR 1,000,000

 

Poster Presentation  
Poster presentation IDR 750,000

 

Conference participant  
Non ISCC member IDR 400,000
ISCC member IDR 350,000

The 3rd International Current Breakthrough in Pharmacy
Conference Chair: Peni Indrayudha

Track 1: Pharmaceutics and Applied Materials for Drug Delivery

Track Director: Anita Sukmawati

Physical pharmacy  pharmaceutics  pharmaceutical technology  drug delivery  pharmaceutical engineering  materials science  nanotechnology  novel development in manufacturing concept of Quality by Design in pharmaceutical product

Track 2: Pharmacology, Toxicology  and Microbiology

Track Director: Zakky Cholisoh

• Experimental animal pharmacology and toxicology • biochemical cellular pharmacology and toxicology • pharmacokinetics • pharmacodynamics, computational prediction of pharmacology • randomised controlled trial • pharmacogenetics • and all aspects of microbiology.

Track 3: Pharmacy Practices and Clinical Pharmacy

Track Director: Hidayah Karuniawati

• Social Pharmacy • Pharmacoeconomics • Pharmacoepidemiology • Pharmacy Management • Pharmacy Practice • Health Related Quality of Life Studies • Hospital pharmacy • Community pharmacy • Public health pharmacy • Clinical medicines • Medication counseling • Therapeutic drug monitoring • Parenteral nutrition • Ambulatory care pharmacy • Oncology pharmacy.

Track 4: Medicinal and Pharmaceutical Chemistry

Track Director: Wahyu Utami

• Pharmaceutical Analysis • Environmental Analysis • Biomedical and Biomolecular Analysis • Analytical instrumentation and Methods • Food Analysis • Biosensor, Biochemistry • Medicinal Chemistry.

Track 5: Pharmacognosy & Ethnobotany

Track Director: Haryoto

• The structural and chemical characterization • the metabolic pathways leading to the synthesis of pharmacologically active compounds • the significance of natural substances in pharmaceutical research • the introducing different ways of applying plant drugs • the effect and use of drugs, herbal extracts and isolated compounds • the collection and cultivation of medicinal plants • breeding strategies and the application of biotechnology • traditional plant usage for food and fodder plants • medicinal plants • fibers and dyeing plants •   the use herbs to treat illness or applying them in a variety of ways.

Track 6: Cancer Chemoprevention

Track Director: Febri Wulandari

• Angiogenesis • invasion and metastasis • antiproliferative • cell cycle • apoptosis • anticancer • immunomodulator • antioxidant • immunotherapy • chemotherapy • carcinogenesis • cancer stem cell • molecular docking • molecular oncology • cancer metabolism • cancer immunology • cancer pharmacogenomic and pharmacogenetic • diagnostics • pharmacotherapy • pharmacoepidemiology • nutraceuticals • cosmeceuticals.

adam_apt's picture

Dr. Adam Hermawan
Pharmaceutical, Biotechnology, Oncology, Molecular Biology
Universitas Gadjah Mada (UGM)
Indonesia
agustono's picture

Dr. Agustono Wibowo
Synthesis and Natural Product Chemistry
Universiti Teknologi MARA (UiTM), Shah Alam
Indonesia
anita's picture

Dr. Anita Sukmawati
Drug Delivery, Tissue Engineering, Biomaterials, Stem Cell, Pharmaceutical technology
Universitas Muhammadiyah Surakarta (UMS)
Indonesia
azissaifudin's picture

Dr. Azis Saifudin
Pharmacognosy, Pharmacology, Natural Product Chemistry, Stereochemistry, Quality Control of Herbal Medicine
Universitas Muhammadiyah Surakarta (UMS)
Indonesia
bambangkuswandi's picture

Prof. Dr. Bambang Kuswandi
Analytical Chemistry
Universitas Jember (UNEJ)
Indonesia
dianalailaramatillah's picture

Dr. Diana Laila Ramatillah
Clinical Pharmacy
Universitas 17 Agustus 1945, Jakarta
Indonesia
edymeiyanto's picture

Prof. Dr. Edy Meiyanto
Pharmaceutical chemistry, Cancer targeted therapy
Universitas Gadjah Mada (UGM)
Indonesia
erindyah's picture

Dr. Erindyah Retno Wikantyasning
Pharmaceutical technology, Nanomedicine
Universitas Muhammadiyah Surakarta (UMS)
Indonesia
erizal's picture

Prof. Dr. Erizal Zaini
Pharmaceutics, solid state characterization
Universitas Andalas
Indonesia
febri's picture

Ms. Febri Wulandari
Cancer chemoprevention
Universitas Gadjah Mada (UGM)
Indonesia
haryoto's picture

Dr. Haryoto
Natural products
Universitas Muhammadiyah Surakarta (UMS)
Indonesia
hidayahkaruniawati's picture

Dr. Hidayah Karuniawati
Clinical Pharmacy
Universitas Muhammadiyah Surakarta (UMS)
Indonesia
maryati's picture

Dr. Maryati
Molecular Biology, Biochemistry
Universitas Muhammadiyah Surakarta (UMS)
Indonesia
mdai's picture

Dr. Muhammad Da'i
Pharmacy, Drug development
Universitas Muhammadiyah Surakarta (UMS)
Indonesia
muthi_ikawati's picture

Dr. Muthi Ikawati
Immunology, Molecular Pathogenesis, Molecular Biology, Biotechnology
Universitas Gadjah Mada (UGM)
Indonesia
peni's picture

Dr. Peni Indrayudha
Protein Pharmaceutics
Universitas Muhammadiyah Surakarta (UMS)
Indonesia
riris_jenie's picture

Dr. Riris Istighfari Jenie
Biochemistry, molecular biology, molecular signal transduction
Universitas Gadjah Mada (UGM)
Indonesia
sahidin's picture

Prof. Dr. Sahidin
Natural Products Chemistry
Haluoleo University
Indonesia
triyulianti's picture

Mrs. Tri Yulianti
Pharmacology, clinical pharmacy
Universitas Muhammadiyah Surakarta (UMS)
Indonesia
wahyuutami's picture

Dr. Wahyu Utami
Pharmacy
Universitas Muhammadiyah Surakarta (UMS)
Indonesia
yana's picture

Prof. Dr. Yana Maolana Syah
Chemistry
Institut Teknologi Bandung (ITB)
Indonesia
zakkycholisoh's picture

Dr. Zakky Cholisoh
pharmacology, clinical pharmacy, pharmacy practice
Universitas Muhammadiyah Surakarta (UMS)
Indonesia

Dr. Atta Abbas Naqvi
Pharmacy Practice
Universiti Sains Malaysia (USM)
Malaysia
khonghy's picture

Prof. Dr. Khong Heng Yen
Natural Products Chemistry
Universiti Teknologi MARA (UiTM), Sarawak
Malaysia
noriz118's picture

Prof. Dr. Norizan Ahmat
Phytochemistry, Natural Product Chemistry, Bio-activity of compounds
Universiti Teknologi MARA (UiTM), Shah Alam
Malaysia

Dr. Wan Isma Hanisa
complementary and alternative medicine, thalassaemia
Universiti Teknologi MARA (UiTM)
Malaysia
fahadob's picture

Dr. Fahad Saleem
Pharmacy Practice
University of Balochistan, Quetta
Pakistan

Dr. Walaa al Badr
Pharmacy
Jeddah University
Saudi Arabia

Ethical guidelines for journal publication

 

Publisher is committed to ensuring ethics in publication and quality of articles.
Conformance to standards of ethical behavior is therefore expected of all parties involved: Authors, Editors, Reviewers, and the Publisher.

In particular,
Authors: Authors should present an objective discussion of the significance of research work as well as sufficient detail and references to permit others to replicate the experiments. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. Review articles should also be objective, comprehensive, and accurate accounts of the state of the art. The authors should ensure that their work is entirely original works, and if the work and/or words of others have been used, this has been appropriately acknowledged. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. Authors should not submit articles describing essentially the same research to more than one journal. The corresponding author should ensure that there is a full consensus of all co-authors in approving the final version of the paper and its submission for publication.

Editors: Editors should evaluate manuscripts exclusively on the basis of their academic merit. An editor must not use unpublished information in the editor's own research without the express written consent of the author. Editors should take reasonable responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper.

Reviewers: Any manuscripts received for review must be treated as confidential documents. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviews should be conducted objectively, and observations should be formulated clearly with supporting arguments, so that authors can use them for improving the paper. Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers

Article withdraw policy
It is a general principle of scholarly communication that the editor/guest editor of a learned journal/series is solely and independently responsible for deciding which articles submitted to the journal shall be published. In making this decision the editor/guest editor is guided by policies of the journal's editorial board and constrained by such legal requirements in force regarding libel, copyright infringement and plagiarism. An outcome of this principle is the importance of the scholarly archive as a permanent, historic record of the transactions of scholarship. Articles that have been published shall remain extant, exact and unaltered as far as is possible. However, very occasionally circumstances may arise where an article is published that must later be retracted or even removed. Such actions must not be undertaken lightly and can only occur under exceptional circumstances, such as:

Article Withdrawal:
Only used for Articles in Press which represent early versions of articles and sometimes contain errors, or may have been accidentally submitted twice. Occasionally, but less frequently, the articles may represent infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like.
Article Retraction:
Infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Occasionally a retraction will be used to correct errors in submission or publication.
Article Removal:
Legal limitations upon the publisher, copyright holder or author(s).
Article Replacement:
Identification of false or inaccurate data that, if acted upon, would pose a serious health risk.


 

Peer Review Process

All submitted full papers will be peer reviewed. The acceptance will be granted if the recommendations from the reviewers are positive. The criteria are based on the technical contents, clarity and format. Authors should make sure the submitted papers use the template for this conference. There are three review processes: Initial Review, Peer Review and Recommendation.

Initial Review

The track director evaluates each manuscript in the submission track to determine if its topic and content is suitable for consideration for the conference before being reviewed. Manuscripts that do not meet minimum criteria are returned to the authors. This is in the best interest of the authors who could then decide to either correct the problems or to submit the manuscript to a more appropriate venue, avoiding delays from a lengthy review process that would nonetheless lead to rejection.

Peer Review

Manuscripts that pass the initial review by the Track Directors, will be sent to several referees based on their expertise. Each manuscript is reviewed by at least two referees. The referees are asked to evaluate the manuscript based on its originality, soundness of methodology, impact to design research, and relevance to design practices. To facilitate timely publication, referees are asked to complete their reviews and provide individual critiques within two weeks. After collecting the referees' reports, the Track Director makes a recommendation on the acceptability of the manuscript.

Acceptance Decision

Based on the referees' comments, the Track Director makes a final decision on the acceptability of the manuscript and communicates to the authors the decision, along with referees' reports. The status reports to reviewers should identify the reviewers of each paper, the final decision can be "Accept Submission", "Revisions Required", or "Decline Submission." The revised version should be submitted considering the review comments.

Plagiarism

The authors should make sure that the manuscript pass a criterion of maximum 30 percents similarities to other publications.